Streetbeat News

DTOC

Digital Transformation Opportunities Corp

dtocorp.com

Open

14.02

Mkt cap

263M

Volume

4.5M

High

32.33

P/E Ratio

649.25

52-wk high

39.60

Low

13.83

Div yield

N/A

52-wk low

7.02

American Oncology Network (AON) and Digital Transformation Opportunities Corp. (DTOC) have completed their previously announced business combination. The combined company will be renamed American Oncology Network, Inc., and its common stock will start trading on the Nasdaq under the ticker symbol 'AONC' from September 21, 2023. AON has grown significantly since its inception in 2018, now including over 1,500 employees and over 200 providers in more than 75 clinics serving over 450,000 patients nationwide. The DTOC partnership and recent strategic investment from AEA Growth will help further AON's goals of supporting community oncology practices and improving the patient experience.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2023 | 6:43 pm

The article lists the stocks that gained and lost the most in Wednesday's mid-day session. Among the gainers were MSP Recovery, Digital Transformation Opportunities Corp., Bluejay Diagnostics, Fresh Tracks Therapeutics, and AgriFORCE Growing Systems. Among the losers were Seelos Therapeutics, ARS Pharmaceuticals, Connexa Sports Technologies, Molekule Group, and IceCure Medical.

Portfolio Pulse from Lisa Levin

September 20, 2023 | 6:10 pm

Shares of Digital Transformation Opportunities Corp. (DTOC) were halted on a circuit breaker after resuming trade, this time to the downside. Despite this, the stock is still up by 89.5%.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2023 | 2:37 pm

Shares of Digital Transformation Opportunities Corp (DTOC) were halted on a circuit breaker due to a significant increase in the stock price. The stock is now up by 60.6%.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2023 | 2:20 pm

Shares of Digital Transformation Opportunities Corp. (DTOC) have resumed trading.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2023 | 2:20 pm

Shares of Digital Transformation Opportunities Corp (DTOC) were halted on a circuit breaker due to a sharp increase in price. The stock is now up by 37.7%.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2023 | 2:11 pm

Shares of several companies including TransCode Therapeutics, Fresh Tracks Therapeutics, EBET, Exscientia, Histogen, Rail Vision, Avinger, Inhibikase Therapeutics, Microbot Medical, and Cheche Group are trading higher in pre-market. Fresh Tracks Therapeutics and Histogen announced plans of liquidation and dissolution. Exscientia and Merck announced collaboration on AI-driven drug discovery. Avinger announced the commercial launch of its Tigereye ST image-guided CTO crossing device. On the other hand, shares of ARS Pharmaceuticals, Connexa Sports Technologies, Bird Global, TD Holdings, AgileThought, Elutia, Digital Transformation Opportunities Corp., Cybin, and Revance Therapeutics are trading lower. ARS Pharmaceuticals received a Complete Response Letter from the FDA for its neffy® Epinephrine nasal spray. Bird Global announced its purchase of micromobility operator Skinny Labs for $19 million. Elutia announced a $26 million private placement of shares.

Portfolio Pulse from Lisa Levin

September 20, 2023 | 12:19 pm

Shares of Digital Transformation Opportunities Corp. (DTOC) are trading lower, following a gain on Monday.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2023 | 5:12 pm

US stocks opened lower with the Dow Jones, NASDAQ, and S&P 500 all falling. Housing starts in the US fell 11.3% MoM to an annualized rate of 1.283 million in August, the lowest level since June 2020. Connexa Sports Technologies, Avinger, and Sezzle saw their shares rise, while Digital Transformation Opportunities Corp., Histogen, and Revance Therapeutics saw their shares fall.

Portfolio Pulse from Lisa Levin

September 19, 2023 | 1:59 pm

Shares of several companies including Connexa Sports Technologies, Elutia, Galera Therapeutics, Senti Biosciences, Neptune Wellness Solutions, Aclarion, Cybin, Avinger, SelectQuote, and Bit Brother Limited are trading higher in pre-market. Elutia's shares rose after the sale of its Orthobiologics business unit to Berkeley Biologics. Galera scheduled a meeting with the FDA to discuss next steps for its radiotherapy avasopasem. Neptune Wellness announced intention to spinout Sprout Organics. Cybin shares surged after hedge fund owner Steve Cohen invested $19 million in the company. On the other hand, shares of Digital Transformation Opportunities Corp., Rocket Lab USA, Novo Integrated Sciences, 60 Degrees Pharmaceuticals, Terran Orbital Corporation, Perspective Therapeutics, MSP Recovery, T2 Biosystems, SCWorx Corp., and FLJ Group Limited are trading lower in pre-market.

Portfolio Pulse from Lisa Levin

September 19, 2023 | 11:59 am

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.